Healthcare provider profile · identity verified

Ernest Carson Alsop, M.D.

Family Practice · ROCKPORT, TX · NPI 1194010504

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	502	139
Lisinopril	Lisinopril	449	123
Levothyroxine Sodium	Levothyroxine Sodium	396	92
Amlodipine Besylate	Amlodipine Besylate	285	70
Pantoprazole Sodium	Pantoprazole Sodium	237	63
Gabapentin	Gabapentin	230	58
Metformin Hcl	Metformin Hcl	221	53
Sertraline Hcl	Sertraline Hcl	221	53
Rosuvastatin Calcium	Rosuvastatin Calcium	196	54
Meloxicam	Meloxicam	187	55
Metoprolol Succinate	Metoprolol Succinate	181	47
Furosemide	Furosemide	163	43
Metformin Hcl Er	Metformin Hcl	160	37
Losartan Potassium	Losartan Potassium	154	47
Simvastatin	Simvastatin	152	42
Cefuroxime	Cefuroxime Axetil	148	113
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	138	21
Tramadol Hcl	Tramadol Hcl	138	45
Potassium Chloride	Potassium Chloride	134	39
Tamsulosin Hcl	Tamsulosin Hcl	132	45
Alprazolam	Alprazolam	123	29
Azithromycin	Azithromycin	122	90
Hydrochlorothiazide	Hydrochlorothiazide	121	33
Trazodone Hcl	Trazodone Hcl	119	36
Pioglitazone Hcl	Pioglitazone Hcl	118	22
Methylprednisolone	Methylprednisolone	117	90
Eliquis	Apixaban	103	22
Glimepiride	Glimepiride	100	26
Omeprazole	Omeprazole	99	24
Escitalopram Oxalate	Escitalopram Oxalate	95	21
Ozempic	Semaglutide	95	17
Montelukast Sodium	Montelukast Sodium	88	48
Metoprolol Tartrate	Metoprolol Tartrate	83	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	81	20
Zolpidem Tartrate	Zolpidem Tartrate	78	17
Diclofenac Sodium	Diclofenac Sodium	77	31
Doxycycline Hyclate	Doxycycline Hyclate	76	62
Famotidine	Famotidine	73	20
Allopurinol	Allopurinol	70	21
Donepezil Hcl	Donepezil Hcl	69	18
Duloxetine Hcl	Duloxetine Hcl	67	18
Tizanidine Hcl	Tizanidine Hcl	65	35
Pravastatin Sodium	Pravastatin Sodium	61	18
Glipizide Er	Glipizide	58	14
Acetaminophen-Codeine	Acetaminophen With Codeine	56	16
Clopidogrel	Clopidogrel Bisulfate	56	16
Ezetimibe	Ezetimibe	56	15
Fluoxetine Hcl	Fluoxetine Hcl	54	12
Cefdinir	Cefdinir	51	36
Clonidine Hcl	Clonidine Hcl	50	12
Bupropion Hcl	Bupropion Hcl	48	13
Irbesartan	Irbesartan	48	14
Valsartan	Valsartan	47	14
Alendronate Sodium	Alendronate Sodium	46	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	29
Spironolactone	Spironolactone	45	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	43	33
Ropinirole Hcl	Ropinirole Hcl	43	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	42	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	13
Carvedilol	Carvedilol	41	13
Lovastatin	Lovastatin	41	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	11
Lorazepam	Lorazepam	38	suppressed
Ondansetron Odt	Ondansetron	38	25
Testosterone Cypionate	Testosterone Cypionate	37	suppressed
Bupropion Hcl Sr	Bupropion Hcl	35	12
Clonazepam	Clonazepam	35	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	34	26
Ciprofloxacin Hcl	Ciprofloxacin Hcl	33	28
Fluconazole	Fluconazole	33	21
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Mounjaro	Tirzepatide	32	suppressed
Ondansetron Hcl	Ondansetron Hcl	32	19
Buspirone Hcl	Buspirone Hcl	31	suppressed
Jardiance	Empagliflozin	30	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Propranolol Hcl	Propranolol Hcl	30	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	18
Atenolol	Atenolol	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	15
Chlorthalidone	Chlorthalidone	25	suppressed
Ketoconazole	Ketoconazole	24	21
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Ibuprofen	Ibuprofen	22	11
Benazepril Hcl	Benazepril Hcl	21	suppressed
Finasteride	Finasteride	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Rizatriptan	Rizatriptan Benzoate	21	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	20	suppressed
Glipizide	Glipizide	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Clindamycin Hcl	Clindamycin Hcl	19	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Temazepam	Temazepam	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Estradiol	Estradiol	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	13
Mirtazapine	Mirtazapine	16	suppressed
Levofloxacin	Levofloxacin	15	13
Nystatin	Nystatin	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Topiramate	Topiramate	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	13	12
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Amoxicillin	Amoxicillin	12	11
Celecoxib	Celecoxib	12	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	suppressed
Digoxin	Digoxin	12	suppressed
Prednisone	Prednisone	12	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Naproxen	Naproxen	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error